Yifeng Pharmacy Chain Co., Ltd.
603939
Kedudukan dalam Saham
#3632
Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical... Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical goods across China. As of March 31, 2021, the company oversaw an expansive network of approximately 6,279 retail pharmacies. These establishments are strategically situated throughout various significant Chinese provinces and municipalities, including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The firm was founded in 2001 and has its primary corporate office located in Changsha, China.
Harga Saham
$3.84
Modal Pasaran
$4.65B
Perubahan (1 hari)
2.73%
Perubahan (1 tahun)
8.86%
Negara
CN
Perdagangan Yifeng Pharmacy Chain Co., Ltd. (603939)
Kategori
Healthcare
Pendapatan untuk Yifeng Pharmacy Chain Co., Ltd. (603939)
Pendapatan pada Jun 2026 TTM: $381.79M
Menurut laporan kewangan terkini Yifeng Pharmacy Chain Co., Ltd., pendapatan semasa syarikat ialah $381.79M. Pada tahun 2023, syarikat memperoleh pendapatan sebanyak $287.85M, peningkatan berbanding pendapatan pada tahun 2022 yang berjumlah $272.18M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Yifeng Pharmacy Chain Co., Ltd. dari 2011 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $381.79M | 27.69% |
| 2024 | $299.00M | 3.87% |
| 2023 | $287.85M | 5.76% |
| 2022 | $272.18M | 29.30% |
| 2021 | $210.50M | 21.98% |
| 2020 | $172.57M | 47.57% |
| 2019 | $116.94M | 38.39% |
| 2018 | $84.50M | 28.43% |
| 2017 | $65.80M | 49.37% |
| 2016 | $44.05M | 19.39% |
| 2015 | $36.90M | 19.46% |
| 2014 | $30.89M | 38.66% |
| 2013 | $22.28M | 49.09% |
| 2012 | $14.94M | 21.08% |
| 2011 | $12.34M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $1.35B | 253.57% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $26.37M | -93.09% |
US
|
|
| - | - |
IT
|
